2021
DOI: 10.1111/ner.13323
|View full text |Cite
|
Sign up to set email alerts
|

Mechanisms for the Clinical Utility of Low-Frequency Stimulation in Neuromodulation of the Dorsal Root Ganglion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
26
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
9
1

Relationship

4
6

Authors

Journals

citations
Cited by 31 publications
(29 citation statements)
references
References 83 publications
3
26
0
Order By: Relevance
“…PPT testing evokes pain from deep soft tissues and thus represents a test method pertaining to the mechanical Aδ‐ and C‐fiber‐mediated 56 component of CLBP. We found that DRG‐S raises PPT in the painful area of the low back in CLBP patients, consistent with the presumed inhibition of nociceptive input with DRG‐S 26,57 . The neuropathic component of CLBP may present as areas of numbness with decreased mechanoreceptive and proprioceptive perception 5–8 .…”
Section: Discussionsupporting
confidence: 74%
“…PPT testing evokes pain from deep soft tissues and thus represents a test method pertaining to the mechanical Aδ‐ and C‐fiber‐mediated 56 component of CLBP. We found that DRG‐S raises PPT in the painful area of the low back in CLBP patients, consistent with the presumed inhibition of nociceptive input with DRG‐S 26,57 . The neuropathic component of CLBP may present as areas of numbness with decreased mechanoreceptive and proprioceptive perception 5–8 .…”
Section: Discussionsupporting
confidence: 74%
“…In the physiologic state, LTMRs typically fire at frequencies of 0.5–5 Hz (24‐26); in vitro studies showed that applying very low‐frequency stimulation to primary afferent neurons at the DRG or the dorsal root reduces excitatory output in the superficial dorsal horn (25‐27). These converging lines of published evidence suggest that a key mechanism of action for DRG‐S is the preferential recruitment of LTMR fibers at very low frequencies to modulate pain transmission through endorphin‐mediated inhibition (18,28).…”
Section: Introductionmentioning
confidence: 99%
“…Through diverse and unique mechanisms of action, DRG-S is being effectively applied in a variety of "off label" pain syndromes. [23][24][25][26][27][28][29] As such, there is an impetus to limit complications, such as lead migration, lead fracture, and the concerns over revision surgery, as these issues have the potential to reduce the therapeutic value of DRG-S to patients. The introduction of the novel paramedian, ipsilateral lead placement technique described in this article for DRG-S implantation seeks to further minimize complications, particularly lead fracture, through leveraging the shared experience and developed techniques of the authors.…”
Section: Discussionmentioning
confidence: 99%